Crossmark

Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults

Crossref DOI link: https://doi.org/10.1007/s12325-023-02490-5

Published Online: 2023-03-21

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

De Greef, Axel https://orcid.org/0000-0003-0713-8283
Ghislain, Pierre-Dominique

de Montjoye, Laurence

Baeck, Marie
License Information

Text and Data Mining valid from 2023-03-21

Version of Record valid from 2023-03-21
More Information

Article History

Received: 30 January 2023

Accepted: 7 March 2023

First Online: 21 March 2023